PET/MR in Oncology: Non-18F-FDG tracers for routine applications

16Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

PET/MR is a new multimodal imaging technique that is expected to improve diagnostic performance, especially in oncologic patients in certain indications. Apart from the clinical relevance of PET with 18F-FDG, various other tracers exist and are increasingly used, which allow insights into multiple physiologic and biologic processes. In this review, we discuss the current and potential future applications of hybrid PET/MR, focusing on non- 18F-FDG tracers. The combination of PET and MR in hybrid whole-body PET/MR systems has the potential to combine excellent morphologic, functional, and biologic information in 1 imaging session with precise image coregistration, thus paving the way for the concept of multimodal multiparametric imaging for future more widespread clinical use. COPYRIGHT © 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author supplied keywords

Cite

CITATION STYLE

APA

Rauscher, I., Eiber, M., Souvatzoglou, M., Schwaiger, M., & Beer, A. J. (2014, June 1). PET/MR in Oncology: Non-18F-FDG tracers for routine applications. Journal of Nuclear Medicine. Society of Nuclear Medicine Inc. https://doi.org/10.2967/jnumed.113.129536

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free